Abstract:Japanese encephalitis virus (JEV), a major cause of Japanese encephalitisis, is an arbovirus that belongs to the genus Flavivirus of the family Flaviviridae. Currently, there is no effective drugs available for the treatment of JEV infection. Therefore, it is important to establish efficient antiviral screening system for the development of antiviral drugs. In this study, we constructed a full-length infectious clone of eGFP-JEV reporter virus by inserting the eGFP gene into the capsid-coding region of the viral genome. The reporter virus RNA transfected-BHK-21 cells generated robust eGFP fluorescence signals that were correlated well with viral replication. The reporter virus displayed growth kinetics similar to wild type (WT) virus although replicated a little slower. Using a known JEV inhibitor, NITD008, we demonstrated that the reporter virus could be used to identify inhibitors against JEV. Furthermore, an eGFP-JEV-based high throughput screening (HTS) assay was established in a 96-well format and used for screening of 1,443 FDA-approved drugs. Sixteen hit drugs were identified to be active against JEV. Among them, five compounds which are lonafarnib, cetylpyridinium chlorid, cetrimonium bromide, nitroxoline and hexachlorophene, are newly discovered inhibitors of JEV, providing potential new therapies for treatment of JEV infection.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop an efficient antiviral screening system for the discovery of antiviral drugs for the treatment of Japanese Encephalitis Virus (JEV) infection. Currently, effective treatment methods for JEV infection do not yet exist, so the establishment of an efficient high - throughput screening (HTS) system is crucial for the research and development of antiviral drugs. To achieve this goal, the researchers constructed a JEV expressing the green fluorescent protein (GFP) reporter gene (eGFP - JEV) and established an eGFP - JEV - based HTS system by optimizing conditions. Specifically: 1. **Construction of eGFP - JEV reporter virus**: By inserting the eGFP gene into the capsid - coding region of the JEV genome, a full - length infectious clone of the eGFP - JEV reporter virus was constructed. This reporter virus can produce a strong eGFP fluorescence signal after transfection into BHK - 21 cells, and these signals are related to the virus replication level. 2. **Verification of the growth kinetics and stability of eGFP - JEV**: The researchers verified the growth kinetics and stability of eGFP - JEV by methods such as immunofluorescence assay (IFA), real - time quantitative PCR (qRT - PCR) and monolayer plaque assay. The results showed that the growth trend of eGFP - JEV was similar to that of wild - type (WT) JEV, and the eGFP gene remained stable in at least four passages. 3. **Verification of the feasibility of the HTS system using known inhibitors**: The researchers used the known JEV inhibitor NITD008 to verify the effectiveness of the eGFP - JEV reporter virus system in antiviral drug screening. The results showed that the inhibitory effect of NITD008 on eGFP - JEV was comparable to its inhibitory effect on WT - JEV, further proving the reliability of this system. 4. **High - throughput screening of the FDA - approved drug library**: Based on the above - optimized conditions, the researchers used the eGFP - JEV reporter virus system to perform high - throughput screening on 1,443 FDA - approved drugs. Eventually, 16 compounds with anti - JEV activity were screened out, among which 5 compounds (lonafarnib, cetylpyridinium chloride, cetrimonium bromide, nitroxoline and hexachlorophene) were reported for the first time to have the activity of inhibiting JEV replication. In summary, the main purpose of this paper is to develop an efficient and reliable high - throughput screening system by constructing and characterizing the eGFP - JEV reporter virus, so as to accelerate the research and development process of anti - JEV drugs.

Generation and characterization of Japanese encephalitis virus expressing GFP reporter gene for high throughput drug screening

Novel antiviral discoveries for Japanese encephalitis virus infections through reporter virus‐based high‐throughput screening

Current Advances in Japanese Encephalitis Virus Drug Development

Screening a neurotransmitter-receptor-related inhibitor library identifies clomipramine HCl as a potential antiviral compound against Japanese encephalitis virus

Development of a recombinant reporter Getah virus for antiviral drug screening assays

Generation of A Stable GFP-reporter Zika Virus System for High-throughput Screening of Zika Virus Inhibitors

Efficient rescue of a newly classified Ebinur lake orthobunyavirus with GFP reporter and its application in rapid antiviral screening

A one-tube rapid visual CRISPR assay for the field detection of Japanese encephalitis virus

A CRISPR-Cas12a-Based Diagnostic Method for Japanese Encephalitis Virus Genotypes I, III, and V

Rapid and simultaneous detection of Japanese encephalitis virus by real-time nucleic acid sequence-based amplification

Natural products and derivatives as Japanese encephalitis virus antivirals

Structure-based Discovery of Antiviral Inhibitors Targeting the E Dimer Interface of Japanese Encephalitis Virus.

Marine Brown Algae-Derived Compounds as Potential Inhibitors of Japanese Encephalitis Virus RNA-Dependent RNA Polymerase

Generation and characterization of a new mammalian cell line continuously expressing virus-like particles of Japanese encephalitis virus for a subunit vaccine candidate

Genomic Characteristics and E Protein Bioinformatics Analysis of JEV Isolates from South China from 2011 to 2018

Gold Nanoparticle-Based RT-PCR and Real-Time Quantitative RT-PCR Assays for Detection of Japanese Encephalitis Virus

Identification and Characterization of Japanese Encephalitis Virus Envelope Protein Gene from Swine

Japanese encephalitis virus JEV replicon vector and application thereof

Engineering the Japanese encephalitis virus RNA genome for the expression of foreign genes of various sizes: Implications for packaging capacity and RNA replication efficiency

A high throughput antiviral screening platform for alphaviruses based on Semliki Forest virus expressing eGFP reporter gene

Construction of an infectious clone of Zika virus stably expressing an EGFP marker in a eukaryotic expression system